RTT News

<img alt="" height="1" width="1" />
Glaxo, Valeant Epilepsy Drug Wins US Backing as Add-On
Bloomberg
GlaxoSmithKline Plc (GSK) and Valeant Pharmaceuticals International Inc. (VRX) won US approval for an epilepsy drug designed as an add-on therapy for patients who aren&#39;t helped by current treatments. ...
FDA Approves Glaxo, Valeant&#39;s Epilepsy DrugRTT News
FDA Clears Valeant and GSK&#39;s Potiga for Partial-Onset Seizures in AdultsGenetic Engineering News
Epilepsy Pill Wins U.S. ApprovalWall Street Journal
StreetInsider.com (subscription) -Pharma Times -Pharmaceutical Business Review
all 50 news articles &raquo;


More...